Semble’s £30M Series C, led by Revaia in June 2026, backs a steady European healthtech thesis: modern, cloud-native software for clinicians replacing aging practice systems.

The problem this startup is attacking

Many healthcare providers still run on outdated, fragmented software. Semble offers a unified, modern platform for records, scheduling, and patient management.

Why this is a live problem now

• Providers want efficiency amid staffing and cost pressures.
• Cloud-native, AI-ready platforms beat legacy systems.
• European health systems are modernizing IT.

Competitive map

• Legacy practice-management and EHR vendors.
• Other European digital-health platforms.
• Regional health-system software incumbents.

Market signal (the number to remember)

• £30M Series C with Partech and Octopus Ventures — durable investor support for clinician-facing software modernization.

Practical takeaway (operator + investor)

Semble shows provider software modernization remains a reliable European category. Founders should emphasize clinician time-savings and interoperability; investors should value recurring revenue and switching costs.

Sources

1. Startuprise (Semble £30M Series C): https://startuprise.co.uk/top-funding-wrap-of-the-week-01-june-05-june-2026/